Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.
Cipla Limited in India has been known for its generic drugs, of which the respiratory drugs made up the largest share of its total revenue with 38.9 percent of contribution in fiscal year 2023. This was followed by the company's anti-infective drugs and cardiac drugs with about 15 and 11 percent share of the revenue respectively.
Revenue share of Cipla Limited in financial year 2023, by medical therapy
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Cipla's gross revenue FY 2015-2023
- Premium Statistic Cipla's BSE market price FY 2021-2023
- Premium Statistic Cipla's shareholders 2023, by type
- Premium Statistic Cipla's API revenue FY 2017-2023
- Premium Statistic Cipla's CSR expenditure 2020 by project
- Premium Statistic Cipla's dividend value FY 2009-2023
- Premium Statistic Cipla's number of employees 2018 by category
- Premium Statistic Cipla's global revenue 2023, by region
- Premium Statistic Cipla's SAGA revenue FY 2017-2018
- Premium Statistic Cipla's EBITDA margin FY 2014-2023
About the region
10
- Premium Statistic Cipla's global revenue share 2023, by region
- Premium Statistic Cipla's R&D investment share FY 2014-2023
- Premium Statistic Cipla's profit FY 2009-2023
- Premium Statistic Cipla's income from operations FY 2014-2023
- Premium Statistic Cipla's global API revenue share 2023, by region
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic GSK Pharmaceuticals' revenue share from operations in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' market price of shares at NSE India FY 2023, by month
- Premium Statistic GSK Pharmaceuticals' profit before tax in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' EBITDA in India FY 2015-2023
Selected statistics
4
Other regions
10
- Premium Statistic Biogen's top products based on revenue 2021-2023
- Premium Statistic Top specialty drug pharmacies in the U.S. by revenue 2023
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Value of pharmaceutical sales in Slovenia 2010-2022
- Basic Statistic Value of pharmaceutical sales in Iceland 2001-2021
- Basic Statistic Value of pharmaceutical sales in Ireland 2010-2021
- Basic Statistic Value of pharmaceutical sales in Austria 2012-2021
Related statistics
10
- Premium Statistic GSK Pharmaceuticals' share of income utilized in India 2023, by category
- Premium Statistic GSK Pharmaceuticals' total income in India FY 2017-2023
- Premium Statistic GSK Pharmaceuticals' number of employees in India FY 2016-2023
- Premium Statistic GSK Pharmaceuticals' remuneration of executive directors in India 2023
- Premium Statistic GSK Pharmaceuticals' operation revenue in India FY 2014-2023
- Premium Statistic GSK Pharmaceuticals' net assets India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' earnings per share in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' shareholder distribution India FY 2023
- Premium Statistic GSK Pharmaceuticals' India equity share capital FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' book value per share India FY 2015-2023
Further related statistics
9
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Per capita consumer spending in India 1974-2012
Further Content: You might find this interesting as well
Statistics
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Per capita consumer spending in India 1974-2012
Cipla. (July 18, 2023). Revenue share of Cipla Limited in financial year 2023, by medical therapy [Graph]. In Statista. Retrieved May 23, 2024, from https://www.statista.com/statistics/986139/india-cipla-revenue-share-by-therapy/
Cipla. "Revenue share of Cipla Limited in financial year 2023, by medical therapy ." Chart. July 18, 2023. Statista. Accessed May 23, 2024. https://www.statista.com/statistics/986139/india-cipla-revenue-share-by-therapy/
Cipla. (2023). Revenue share of Cipla Limited in financial year 2023, by medical therapy . Statista. Statista Inc.. Accessed: May 23, 2024. https://www.statista.com/statistics/986139/india-cipla-revenue-share-by-therapy/
Cipla. "Revenue Share of Cipla Limited in Financial Year 2023, by Medical Therapy ." Statista, Statista Inc., 18 Jul 2023, https://www.statista.com/statistics/986139/india-cipla-revenue-share-by-therapy/
Cipla, Revenue share of Cipla Limited in financial year 2023, by medical therapy Statista, https://www.statista.com/statistics/986139/india-cipla-revenue-share-by-therapy/ (last visited May 23, 2024)
Revenue share of Cipla Limited in financial year 2023, by medical therapy [Graph], Cipla, July 18, 2023. [Online]. Available: https://www.statista.com/statistics/986139/india-cipla-revenue-share-by-therapy/